21
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Mitochondrial DNA Depletion in Respiratory Chain–Deficient Parkinson Disease Neurons

      research-article
      , PhD 1 , 2 , 3 , , , PhD 1 , , MSc 1 , , PhD 4 , , PhD, DHom 5 , , MD, PhD, FRCP 1
      Annals of Neurology
      John Wiley and Sons Inc.

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          To determine the extent of respiratory chain abnormalities and investigate the contribution of mtDNA to the loss of respiratory chain complexes (CI–IV) in the substantia nigra (SN) of idiopathic Parkinson disease (IPD) patients at the single‐neuron level.

          Methods

          Multiple‐label immunofluorescence was applied to postmortem sections of 10 IPD patients and 10 controls to quantify the abundance of CI–IV subunits (NDUFB8 or NDUFA13, SDHA, UQCRC2, and COXI) and mitochondrial transcription factors (TFAM and TFB2M) relative to mitochondrial mass (porin and GRP75) in dopaminergic neurons. To assess the involvement of mtDNA in respiratory chain deficiency in IPD, SN neurons, isolated with laser‐capture microdissection, were assayed for mtDNA deletions, copy number, and presence of transcription/replication‐associated 7S DNA employing a triplex real‐time polymerase chain reaction (PCR) assay.

          Results

          Whereas mitochondrial mass was unchanged in single SN neurons from IPD patients, we observed a significant reduction in the abundances of CI and II subunits. At the single‐cell level, CI and II deficiencies were correlated in patients. The CI deficiency concomitantly occurred with low abundances of the mtDNA transcription factors TFAM and TFB2M, which also initiate transcription‐primed mtDNA replication. Consistent with this, real‐time PCR analysis revealed fewer transcription/replication‐associated mtDNA molecules and an overall reduction in mtDNA copy number in patients. This effect was more pronounced in single IPD neurons with severe CI deficiency.

          Interpretation

          Respiratory chain dysfunction in IPD neurons not only involves CI, but also extends to CII. These deficiencies are possibly a consequence of the interplay between nDNA and mtDNA‐encoded factors mechanistically connected via TFAM. ANN NEUROL 2016;79:366–378

          Related collections

          Most cited references31

          • Record: found
          • Abstract: found
          • Article: not found

          Stages in the development of Parkinson's disease-related pathology.

          The synucleinopathy, idiopathic Parkinson's disease, is a multisystem disorder that involves only a few predisposed nerve cell types in specific regions of the human nervous system. The intracerebral formation of abnormal proteinaceous Lewy bodies and Lewy neurites begins at defined induction sites and advances in a topographically predictable sequence. As the disease progresses, components of the autonomic, limbic, and somatomotor systems become particularly badly damaged. During presymptomatic stages 1-2, inclusion body pathology is confined to the medulla oblongata/pontine tegmentum and olfactory bulb/anterior olfactory nucleus. In stages 3-4, the substantia nigra and other nuclear grays of the midbrain and forebrain become the focus of initially slight and, then, severe pathological changes. At this point, most individuals probably cross the threshold to the symptomatic phase of the illness. In the end-stages 5-6, the process enters the mature neocortex, and the disease manifests itself in all of its clinical dimensions.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Mitochondrial transcription factor A regulates mtDNA copy number in mammals.

            Mitochondrial DNA (mtDNA) copy number regulation is altered in several human mtDNA-mutation diseases and it is also important in a variety of normal physiological processes. Mitochondrial transcription factor A (TFAM) is essential for human mtDNA transcription and we demonstrate here that it is also a key regulator of mtDNA copy number. We initially performed in vitro transcription studies and determined that the human TFAM protein is a poor activator of mouse mtDNA transcription, despite its high capacity for unspecific DNA binding. Next, we generated P1 artificial chromosome (PAC) transgenic mice ubiquitously expressing human TFAM. The introduced human TFAM gene was regulated in a similar fashion as the endogenous mouse Tfam gene and expression of the human TFAM protein in the mouse did not result in down-regulation of the endogenous expression. The PAC-TFAM mice thus had a net overexpression of TFAM protein and this resulted in a general increase of mtDNA copy number. We used a combination of mice with TFAM overexpression and TFAM knockout and demonstrated that mtDNA copy number is directly proportional to the total TFAM protein levels also in mouse embryos. Interestingly, the expression of human TFAM in the mouse results in up-regulation of mtDNA copy number without increasing respiratory chain capacity or mitochondrial mass. It is thus possible to experimentally dissociate mtDNA copy number regulation from mtDNA expression and mitochondrial biogenesis in mammals in vivo. In conclusion, our results provide genetic evidence for a novel role for TFAM in direct regulation of mtDNA copy number in mammals.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.

              Four persons developed marked parkinsonism after using an illicit drug intravenously. Analysis of the substance injected by two of these patients revealed primarily 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) with trace amounts of 1-methyl-4-phenyl-4-propionoxy-piperidine (MPPP). On the basis of the striking parkinsonian features observed in our patients, and additional pathological data from one previously reported case, it is proposed that this chemical selectively damages cells in the substantia nigra.
                Bookmark

                Author and article information

                Journal
                Ann Neurol
                Ann. Neurol
                10.1002/(ISSN)1531-8249
                ANA
                Annals of Neurology
                John Wiley and Sons Inc. (Hoboken )
                0364-5134
                1531-8249
                28 January 2016
                March 2016
                : 79
                : 3 ( doiID: 10.1002/ana.v79.3 )
                : 366-378
                Affiliations
                [ 1 ] Wellcome Trust Centre for Mitochondrial Research and Medical Research Council/Biotechnology and Biological Sciences Research Council Centre for Ageing and Vitality Institute of Neurosciences, Newcastle University Newcastle upon TyneUnited Kingdom
                [ 2 ] Institute of NeurogeneticsUniversity of Lübeck LübeckGermany
                [ 3 ] Molecular and Functional Neurobiology Group, Luxembourg Center for Systems BiomedicineUniversity of Luxembourg, Campus Belval BelvauxLuxembourg
                [ 4 ] Newcastle Brain Tissue Resource, Campus for Ageing and VitalityNewcastle University Newcastle upon TyneUnited Kingdom
                [ 5 ] Division of Behavioral Medicine, Department of Psychiatry and Department of Neurology, College of Physicians and Surgeons Columbia University, Columbia University Medical Center New York NY
                Author notes
                [*] [* ]Address correspondence to Dr Grünewald, Institute of Neurogenetics, University of Lübeck, Maria‐Goeppert‐Str. 1, 23562 Lübeck, Germany. E‐mail: anne.gruenewald@ 123456neuro.uni-luebeck.de
                Article
                ANA24571
                10.1002/ana.24571
                4819690
                26605748
                4d816636-4add-4556-95fe-73809143a877
                © 2016 The Authors. Annals of Neurology published by Wiley Periodicals, Inc. on behalf of American Neurological Association

                This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 22 July 2015
                : 24 November 2015
                Page count
                Pages: 13
                Funding
                Funded by: Newcastle University Centre for Brain Ageing and Vitality
                Funded by: Biotechnology and Biological Sciences Research Council
                Funded by: Engineering and Physical Sciences Research Council
                Funded by: Economic and Social Research Council
                Funded by: Medical Research Council
                Award ID: G0700718
                Funded by: Wellcome Trust Centre for Mitochondrial Research
                Award ID: G906919
                Funded by: MRC Centre for Translational Research in Neuromuscular Disease Mitochondrial Disease Patient Cohort
                Award ID: G0800674
                Funded by: UK National Institute for Health Research (NIHR) Biomedical Research Centre in Age and Age Related Diseases
                Funded by: Newcastle upon Tyne Hospitals National Health Service (NHS) Foundation Trust
                Funded by: UK NHS Specialist Commissioners “Rare Mitochondrial Disorders of Adults and Children” Service
                Funded by: German Research Foundation
                Funded by: Luxembourg National Research Funds
                Funded by: UK MRC
                Award ID: G0400074
                Funded by: Alzheimer's Society and Alzheimer's Research Trust
                Funded by: Brains for Dementia Research Initiative
                Funded by: NIHR Biomedical Research Centre Grant in Ageing and Health
                Funded by: NIHR Biomedical Research Unit in Lewy Body Dementia
                Categories
                Research Article
                Research Articles
                Custom metadata
                2.0
                ana24571
                March 2016
                Converter:WILEY_ML3GV2_TO_NLMPMC version:4.8.6 mode:remove_FC converted:15.04.2016

                Neurology
                Neurology

                Comments

                Comment on this article